{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:39:00Z","timestamp":1778661540788,"version":"3.51.4"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,27]]},"DOI":"10.1097\/01.tp.0000203556.06145.5b","type":"journal-article","created":{"date-parts":[[2006,3,27]],"date-time":"2006-03-27T11:16:49Z","timestamp":1143458209000},"page":"818-825","source":"Crossref","is-referenced-by-count":37,"title":["Extending Postgrafting Cyclosporine Decreases the Risk of Severe Graft-versus-Host Disease after Nonmyeloablative Hematopoietic Cell Transplantation"],"prefix":"10.1097","volume":"81","author":[{"given":"Lauri","family":"Burroughs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Mielcarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Leisenring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda M.","family":"Sandmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.D.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Chauncey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetto","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Storb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210129","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1182\/blood-2004-02-0545","article-title":"Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplant comorbidities.","volume":"104","author":"Sorror","year":"2004","journal-title":"Blood"},{"key":"R2-2-20210129","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood-2004-03-0804","article-title":"Morbidity and mortality with nonmyeloablative compared to myeloablative conditioning before hematopoietic cell transplantation from HLA matched related donors.","volume":"104","author":"Diaconescu","year":"2004","journal-title":"Blood"},{"key":"R3-2-20210129","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","article-title":"Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.","volume":"102","author":"Mielcarek","year":"2003","journal-title":"Blood"},{"key":"R4-2-20210129","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1056\/NEJM198202183060703","article-title":"A randomized study of the prevention of acute graft-versus-host disease.","volume":"306","author":"Ramsay","year":"1982","journal-title":"N Engl J Med"},{"key":"R5-2-20210129","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2141.1989.tb04325.x","article-title":"Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: Long-term follow-up of a controlled trial.","volume":"72","author":"Storb","year":"1989","journal-title":"Br J Haematol"},{"key":"R6-2-20210129","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.","volume":"314","author":"Storb","year":"1986","journal-title":"N Engl J Med"},{"key":"R7-2-20210129","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.V73.6.1729.1729","article-title":"Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial.","volume":"73","author":"Storb","year":"1989","journal-title":"Blood"},{"key":"R8-2-20210129","first-page":"2605","article-title":"A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: Methotrexate\/prednisone v cyclosporine A\/prednisone.","volume":"19","author":"Forman","year":"1987","journal-title":"Transplant Proc"},{"key":"R9-2-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1399-0012.1987.tb00685.x","article-title":"Cyclosporine plus methylprednisolone versus cyclophosphamide plus methylprednisolone as prophylaxis for graft-versus-host disease: A randomized double-blind study in patients undergoing allogeneic marrow transplantation.","volume":"1","author":"Santos","year":"1987","journal-title":"Clin Transplant"},{"key":"R10-2-20210129","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.V76.5.1037.1037","article-title":"What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?","volume":"76","author":"Storb","year":"1990","journal-title":"Blood"},{"key":"R11-2-20210129","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM199310213291703","article-title":"Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.","volume":"329","author":"Chao","year":"1993","journal-title":"N Engl J Med"},{"key":"R12-2-20210129","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1182\/blood.V89.10.3880","article-title":"Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.","volume":"89","author":"Deeg","year":"1997","journal-title":"Blood"},{"key":"R13-2-20210129","first-page":"2303","article-title":"Phase III study comparing methotrexate and tacrolimus (Prograf, FK506) with methotrexate and cyclosporine for graft-versus-host-disease prophylaxis after HLA-identical sibling bone marrow transplantation.","volume":"92","author":"Ratanatharathorn","year":"1998","journal-title":"Blood"},{"key":"R14-2-20210129","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood.V96.7.2391","article-title":"Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.","volume":"96","author":"Ruutu","year":"2000","journal-title":"Blood"},{"key":"R15-2-20210129","first-page":"1690","article-title":"Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO\/EBMT randomized trial.","volume":"96","author":"Locatelli","year":"2000","journal-title":"Blood"},{"key":"R16-2-20210129","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.","volume":"96","author":"Nash","year":"2000","journal-title":"Blood"},{"key":"R17-2-20210129","doi-asserted-by":"crossref","first-page":"349a","DOI":"10.1182\/blood.V104.11.1236.1236","article-title":"Evaluation of three different cyclosporine-based graft versus host disease (GVHD) prophylaxis regimens following nonmyeloablative hematopoietic stem cell transplantation (NST).","volume":"104","author":"Srinivasan","year":"2004","journal-title":"Blood"},{"key":"R18-2-20210129","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood.V89.8.3048","article-title":"Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.","volume":"89","author":"Storb","year":"1997","journal-title":"Blood"},{"key":"R19-2-20210129","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood-2003-02-0482","article-title":"HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.","volume":"102","author":"Maris","year":"2003","journal-title":"Blood"},{"key":"R20-2-20210129","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","article-title":"Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases.","volume":"101","author":"Niederwieser","year":"2003","journal-title":"Blood"},{"key":"R21-2-20210129","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","article-title":"Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.","volume":"97","author":"McSweeney","year":"2001","journal-title":"Blood"},{"key":"R22-2-20210129","first-page":"145a","article-title":"Low dose TBI conditioning for hematopoietic stem cell transplants (HSCT) from HLA-matched related donors for patients with hematologic malignancies: influence of fludarabine or cytoreductive autografts on outcome.","volume":"100","author":"Sandmaier","year":"2002","journal-title":"Blood"},{"key":"R23-2-20210129","first-page":"78a","article-title":"Low-dose total body irradiation (TBI) conditioning for hematopoietic cell transplants (HCT) from HLA-matched related (MRD) and unrelated (URD) donors for patients with hematologic malignancies: a five-year experience.","volume":"102","author":"Sandmaier","year":"2003","journal-title":"Blood"},{"key":"R24-2-20210129","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading.","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R25-2-20210129","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation.","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol"},{"key":"R26-2-20210129","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","article-title":"Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.","volume":"80","author":"Nash","year":"1992","journal-title":"Blood"},{"key":"R27-2-20210129","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","article-title":"Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.","volume":"300","author":"Weiden","year":"1979","journal-title":"N Engl J Med"},{"key":"R28-2-20210129","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJM198302103080602","article-title":"Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.","volume":"308","author":"Storb","year":"1983","journal-title":"N Engl J Med"},{"key":"R29-2-20210129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"R30-2-20210129","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.2005.08.136","article-title":"Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.","volume":"23","author":"Baron","year":"2005","journal-title":"J Clin Oncol"},{"key":"R31-2-20210129","first-page":"194","article-title":"Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?","volume":"3","author":"Storb","year":"1997","journal-title":"Biol Blood and Marrow Transplantation"},{"key":"R32-2-20210129","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1182\/blood.V98.13.3868","article-title":"Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial (Brief Report).","volume":"98","author":"Kansu","year":"2001","journal-title":"Blood"},{"key":"R33-2-20210129","first-page":"341","article-title":"Cyclosporin A and chronic graft versus host disease.","volume":"6","author":"Bacigalupo","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"R34-2-20210129","first-page":"315","article-title":"One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.","volume":"88","author":"Mengarelli","year":"2003","journal-title":"Haematologica"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-200603270-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T04:19:48Z","timestamp":1736309988000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200603270-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,27]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000203556.06145.5b","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3,27]]}}}